GSK gets first approval for two-drug HIV treatment
GSK’s Dovato is approved by the US FDA for the treatment of individuals with HIV with no previous antiretroviral therapy, in a first for a two-drug, fixed-dose, complete regimen.
Archives for April 9, 2019
Clinerion’s network expands into India with AlphaMD partnership
Clinerion expands into India’s hospital ecosystem to accelerate trial recruitment and site selection as it partners Alpha MD.
GE’s Edison partnership with ACR AI-Lab to aid algorithm development
GE Healthcare’s Edison platform collaborates with ACR AI-Lab to extend its AI capabilities and allows ACR members access to algorithm creation in an aim to turn research into product development.
$14m financing bolsters Deep Lens digital pathology platform
Deep Lens closes $14m Series A financing as it continues to expand its digital pathology platform to enable patient identification at time of diagnosis, fast-tracking trial enrollment.
WuXi NextCode’s new lab to support next-gen sequencing for clinical trials
The global genomic data and insights company expands its US footprint with the addition of a new genetic analysis laboratory as part of its mission to improve lives through genomics.
Merck KGaA receives approval for oral dose MS treatment
The company’s Mavenclad treatment gains approval from the US FDA for the treatment of multiple sclerosis, eight years after it had been initially rejected.